OnabotulinumtoxinA Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications

被引：0
|
作者：
Farrelly, E. [1 ]
Lorenzo-Gomez, M. [2 ]
Schulte-Baukloh, H. [3 ]
Nelson, M. [4 ]
Hamid, R. [5 ]
机构：
[1] Stockholm South Gen Hosp, Sodersjukhuset, Stockholm, Sweden
[2] Univ Hosp Salamanca, Salamanca, Spain
[3] St Hedwig Krankenhaus, Berlin, Germany
[4] AbbVie, N Chicago, IL USA
[5] Univ Coll London Hosp, London, England
来源：
INTERNATIONAL UROGYNECOLOGY JOURNAL | 2022年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
340
引用
收藏
页码：S408 / S409
页数：2
相关论文
共 50 条
  • [1] ONABOTULINUMTOXINA IMPROVES IDIOPATHIC OVERACTIVE BLADDER SYMPTOMS IN PATIENTS REFRACTORY TO ORAL MEDICATIONS
    Farrelly, Elisabeth Carlsson
    Lorenzo-Gomez, Maria-Fernando
    Schulte-Baukloh, Heinrich
    Nelson, Mariana
    Hamid, Rizwan
    JOURNAL OF UROLOGY, 2022, 207 (05): : E222 - E222
  • [2] OnabotulinumtoxinA Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria-Fernando
    Schulte-Baukloh, Heinrich
    Nelson, Mariana
    Hamid, Rizwan
    TOXICON, 2022, 214 : S62 - S62
  • [3] One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications
    Farrelly, Elisabeth
    Hamid, Rizwan
    Lorenzo-Gomez, Maria-Fernanda
    Schulte-Baukloh, Heinrich
    Yu, Jun
    Patel, Anand
    Nelson, Mariana
    NEUROUROLOGY AND URODYNAMICS, 2023, 42 (06) : 1203 - 1213
  • [4] The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty
    El-Azab, Ahmed S.
    Moeen, Ahmed M.
    ARAB JOURNAL OF UROLOGY, 2013, 11 (04) : 344 - 349
  • [5] ONABOTULINUMTOXINA IMPROVES SYMPTOMS OF OVERACTIVE BLADDER, INCLUDING NOCTURIA
    Nitti, Victor
    Dmochowski, Roger
    Sand, Peter
    Thompson, Catherine
    Yan, Xiaohong
    Herschorn, Sender
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 109 - 110
  • [6] Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial
    Boone T.B.
    Current Bladder Dysfunction Reports, 2011, 6 (2) : 65 - 66
  • [7] OnabotulinumtoxinA for Idiopathic Overactive Bladder Symptoms: Many Answers but More Questions
    Madersbacher, Stephan
    EUROPEAN UROLOGY, 2013, 64 (02) : 257 - 259
  • [8] Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder
    Tay, Li June
    Harry, Deepak
    Malde, Sachin
    Sahai, Arun
    UROLOGY, 2021, 149 : 1 - 10
  • [9] ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Khullar, V.
    Sand, P.
    Parsons, M.
    Zhou, J.
    Globe, D.
    Nardo, C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S13 - S14
  • [10] Adding mirabegron after intravesical onabotulinumtoxinA injection improves therapeutic effects in patients with refractory overactive bladder
    Wang, Chung-Cheng
    Lee, Cheng-Ling
    Hwang, Yi-Ting
    Kuo, Hann-Chorng
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2021, 13 (04) : 440 - 447
12345